Stanford Neurology & Neurological Sciences

08/15/2025

There is no cure for Parkinson’s, but treatments can improve your symptoms and quality of life. We offer advanced treatments, therapy, and support.

https://stan.md/411NFk2

07/29/2025

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

06/22/2025

06/18/2025

At the Stanford Health Care Multiple Sclerosis Center, our specialists have extensive experience in treating complex and rare neurological conditions.

https://stan.md/3G89bfP

06/18/2025

DIPG is one of the most aggressive brain tumors, particularly devastating for children. Dr. Michelle Monje is leading innovative research in cancer neuroscience to combat these brain tumors. https://stanmed.stanford.edu/stopping-cancer-nervous-system-infiltration/

Stanford Medicine scientists founded a new field of cancer biology by showing how cancer cells tap into the nervous system.

06/10/2025

Neurologist Helen Bronte-Stewart has led groundbreaking research that culminated in the FDA's recent approval of adaptive deep brain stimulation (aDBS), a personalized treatment for Parkinson’s disease. This innovative technology adjusts electrical pulses based on individual brain signals, offering a more effective and tailored approach to managing symptoms for millions affected by the condition.

We speak with neurologist Helen Bronte-Stewart, who conducted research that led to the development of a technology recently approved by the U.S. Food and Drug Administration.

05/30/2025

Stanford neuro-oncologist Michelle Monje is pursuing a cure for a deadly pediatric brain cancer – and reshaping our understanding of how cancer and brain development intersect.

05/21/2025

PSP-MSA-CBD Caregiving Symposium
Saturday, June 14, 2025, 10am-3pm PT
Online and In-Person (Stanford Campus)

This event is designed specifically for caregivers, partners, and family members who care for those with:
• progressive supranuclear palsy (PSP)
• multiple system atrophy (MSA)
• corticobasal degeneration (CBD) (Also referred to as corticobasal syndrome, or CBS.)

Register now! Space is limited (particularly for in-person attendance). The in-person event is for caregivers only. Obviously this doesn't apply to online attendance though the program is focused on caregiving.

There is a small registration fee. Scholarships are available.

Speakers include a Stanford movement disorder specialist on what caregivers can do for these three atypical parkinsonism disorders; a psychologist on the caregiver's journey; two social workers on the effects of neurological decline on the family unit; and a panel of PSP, MSA, and CBD caregivers, many of whom are Brain Support Network group members.

Attend Online
bit.ly/june14atypical-virtual
Registration ends on June 14, 11am PT

Attend In Person on Stanford Campus
bit.ly/june14atypical-campus
Registration ends on June 12, noon PT

05/20/2025

🎧 PODCAST 🎧 Inside the Epileptic Brain: How Myelin Plasticity Could Change Epilepsy Care

In this episode, Dr. explores how targeting myelination could change

https://ow.ly/zCSB50VHlTG (Episode 102)

05/19/2025

New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

05/14/2025

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

05/13/2025

In the Tri-Valley region, hundreds of thousands of residents have relied on ValleyCare Health System since it opened its doors as a resident-funded 46-bed hospital in 1961. For more than six decades, the organization has grown alongside the surrounding population into a health care institution to meet the diverse health care needs of the community. In 2015, with the support and approval of ValleyCare corporate members, ValleyCare affiliated with Stanford Medicine.

Reflecting on the last 10 years, the organization — now known as Stanford Health Care Tri-Valley — has strategically built upon ValleyCare’s rich history and strong foundation to provide top-tier health care by and for the local community by investing heavily in infrastructure, people, clinical care and technology.